Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Biotechnology (Биотехнология). Учебно-методическое пособие

.pdf
Скачиваний:
0
Добавлен:
07.09.2026
Размер:
2 Мб
Скачать
land area by 2032. The "World Atlas of Biodiversity: Earth's Living Resources for the 21st Century" report said that as much as 48 percent of these areas will become converted to agricultural land, plantations and urban areas, compared with 22 percent today.
"By slowing the rate at which natural habitats are destroyed, GM crops and other technologies that increase agricultural productivity can help to preserve natural biodiversity," said Ammann of the University of Bern.
Bioethics: the future from a test-tube
More than forty years have elapsed since the discovery by James Watson and Francis Crick of a "double spiral" — the DNA molecule. Considerable headway has been made in the field of biology and gene engineering since then, but there are a number of reasons holding back the advance of these research studies. "Today we are in a position to cure Alzheimer disease, but just one injection from a course costs about a million French francs. Methods do exist, but all of them are linked to either economic or ethical problems," admitted one participant in the session, the Secretary-General of the Stockholm International Research Organization.
Laws on bioethics have been passed recently in several countries to somehow adjust the problems that keep arising and to fix the framework which research and practice must not transcend. But these laws vary from country to country. For example, while laboratory tests on the human embryo have been banned with rare exceptions in Germany, such operations can be carried out in Britain but on the condition that the embryo's age does not exceed two weeks.
It is obvious that the research studies being carried out in the field of genetics cannot be halted - for their results will enable mankind to rid itself of such diseases as haemophilia or inherited infantile paralysis. In the view of Prof. Osuntokun of the University of Ibadan, Nigeria, the methods of gene engineering will make it possible to wage an effective struggle against tropical diseases which now plague the population of Third World countries.
But, on the other hand, there is quite a number of warranted and unwarranted apprehensions and questions. How should the law treat the creation of chimeras and cloning? If impregnation "in vitro" exists, is there moral justification for the bearing of the human foetus not by its natural mother and even not by a human? Can use be made for such impregnation of the frozen gene material of a deceased person? Is it possible to demand and issue a patent for the human gene?
This is a far from complete list of questions now facing medics and biologists, sociologists and jurists, philosophers and theologians. The
131
International Committee on Bioethics, whose first session took place in Paris, was created under UNESCO's aegis precisely for the purpose of elaborating a universal approach for different cultures and peoples towards the problem of the human genome. The list of participants in this committee is too long. Suffice to say that it includes three Nobel laureates (Sydney Altaian, Christian de Duve and Jean Dausset), also represented on it, besides biologists and medics, are jurists, economists, sociologists, writers and even a spokesman for the Vatican. The principles on which it is going to build its activities were expressed most aptly, perhaps, by Dr. Michel Renel of the world-famous Weizmann Institute of Science in Israel which uses genetic means to combat cancer: "Man is not a creature which is determined merely by a collection of genes, it is impossible to see this alone and forget that first and foremost he is determined by culture"62.
62
http://www.annualreviews.org/doi/abs/10.1146/annurev.ecolsys.30.1.539
132
Text 7. The Nucleus, Genetic Information and Its Transmission
Genetic information is the set of data determining the structural and functional properties of cells. Genetic information is stored in the cell nucleus, in molecules of DNA (or, more accurately, in the sequence of nucleotides in these DNA molecules) and it serves the cell as a guide to act in different situation. After cell division it controls the synthesis of structural proteins and enzymes required for cell function; it takes part in growth and cell differentiation. In differentiated cells it participates in the regulation of metabolic processes (induction and repression).
The site of genetic information in a cell is the nucleus or, in prokaryotic cells and autonomous cell organelles, the circular chromosome. The nucleus is a morphologically distinct organelle separated from the cytoplasm by the nuclear membrane. It is in fact a double membrane involuted so as to form pores with apparent diameter of 3C to 100 mm through which macromolecules can pass when necessary. In addition to this unique structure, the nuclear membrane participates directly in the replication of DNA and may communicate with the extracellular medium. Much of the nuclear material is in fact deoxyribonucleic acid (DNA) which, in an interphase nucleus, forms filaments of variable thickness (10 mm on the average but occasionally only 2 mm). The thickness of these filaments depends on the presence or absence of proteins surrounding the double helix of DNA. The length of these filaments depends on the molecular weight of DNA, one chromosome (about 1010 molecular weight) containing DNA several cm long. The DNA content of the nucleus depends on the animal species (about 6 pg per mammalian cell) and is rather constant in different cells, of a given species.
Ribonucleic acids (RNA) accumulate mainly in the nucleolus, enclosed in the nuclear membrane. Their size and function will be described in the following chapter.
Nuclear proteins can be divided into histones and nonhistone proteins. Histones are classified into five groups differing by size, charge (always positive) and amino acid composition. Their function consists in organizing the long filaments of DNA into more compact forms (superhelix). This is accomplished by electrostatic interaction of histones with the negatively charged phosphate groups of DNA. The composition of non-histonc proteins is not fully known hut they appear to be phosphorelated, acidic proteins. They are responsible for a selective and transient inhibition of RNA transcription through binding to certain segments of DNA and for regulating the transcription of histone genes.
133
Besides the macro molecules, the nucleus contains low-molecular weight compounds and ions, especially Mg2+ and K+.
DNA molecules are polynucleotides, i.e. chains composed of mononucleotides. The principal backbone of DNA molecules is formed by a sequence of deoxyribose molecules alternating with phosphate residues, linked by diester bonds in such a way that the 5'-OH group of deoxyribose molecules is esterified by phosphoric acid which is attached to the 3'-OH group of deoxyribose of the neighboring nucleotide. DNA molecules contain pyrimidine bases thymine T, cytosine C) and purine bases (adenine A, guanine G). These bases are attached to the C1 of deoxyribose by a N- glycosidic bond to N3 of pyrimidines and to N9 of purines. The base sequence is highly specific for every DNA molecule.
In solution, DNA molecules assume the structure of a double helix (Watson and Crick). The strands are connected with each other through hydrogen bonds formed between juxtaposed bases A-T (two hydrogen bonds) and C-G (3 hydrogen bonds); they are stabilized by hydrophobic interactions between neighboring bases of the same strand; the double-helix structure is supported longitudinally by molecules of basic proteins which are localized in the groove of the double helix.
In addition to the double-stranded form there, exist DNA's in the form of a closed circle, either one or several arranged like links in a chain (in mitochondria, bacteria, viruses). In a chromosome, a supercoil (a coiled double helix) is formed to achieve maximum condensation of material.
DNA molecules are synthesized from deoxyribonucleotides in the presence of a template (i.e., one of the DNA strands whose nucleotide sequence will be exactly reproduced step by step) and of enzymes. DNA biosynthesis requires sufficient supply of all the deoxyribonucleotides (dTTP, dATP, dGTP, dCTP)63.
63
Мельникова В.А., Барановская М.Е., Халикова Д.Г. Microbiology and
Biotechnology. Указ. соч.
134
Text 8. Principles of Metabolic Control
Cells and organisms are relatively isolated systems in a quasi­steady state. The functions of living organisms as a whole as well as of their parts are regulated with the objective of attaining maximum survival. Since the living system reacts in space and time, both spatial and temporal regulation may be employed.
Space comes into play mainly in the higher degree of organization of structures; maintenance of structural stability of proteins, association of cooperating enzymes into multienzyme complexes, their localization in definite compartments (mitochondria, endoplasmic reticulum) and specialization of cells and tissues by differentiation processes.
Time is involved in regulation mainly in terms of modification if reaction rates (metabolic, transport, and others). In practice, both dimensions are utilized simultaneously.
Regulatory mechanisms become effective at very different levels of organization but their basis is always molecular. Functions of an organism can be regulated through reactions taking place in cells (metabolic regulation) and at the level of the whole organism (hormonal, nervous controls). Within a cell, metabolic "processes are controlled mainly by regulating the activity of individual enzymes.
Enzymes can be regulated in several ways:
1. By changing the concentration of substrates or coenzymes (a metabolic signal) that result in changes of enzyme activity, the amount of the enzyme involved remaining constant. Changes in the concentration of a signal compound are mostly achieved through compartmentation, i.e. by forming membranes separating the cell from the extracellular milieu and smaller compartments within the cell, these being separated spatially (by membranes) or functionally (carriers).
2. By changing the concentration of effectors (activators and inhibitors) in allosteric enzymes. By interacting with the allosteric site of the enzyme, such effectors can increase or decrease the enzyme activity on the basis of cooperative changes of conformation of the subunits, from which the enzyme is composed. The amount of the allosteric enzyme is not changed during the process.
3. By induction or repression when, in contrast with the two preceding mechanisms, the amount of enzyme and hence its total activity in the system is changed. The enzyme quantity per cell depends on presence of a represser protein which is coded by a regulator gene and which, in its active form, inhibits the synthesis of some enzymes
135
(repression). Some low-molecular weight compounds (inducers) can interact with the represser and change it to an inactive form which cannot inhibit the synthesis of the given enzyme — this is the induction of their synthesis (derepression).
Multi-enzyme systems are those in which the individual enzymes are organized in such a way that the product of one enzyme reaction serves as substrate for the next. Here again, feedback regulation plays an important role, a product of a reaction sequence controlling the activity of one of the preceding enzymes, usually the first of the sequence.
Regulation at the level of an organism requires the existence of special differentiated cells and structures with control function (nerve cells, endocrine glands). These cells are known to produce certain compounds that can be considered as material carriers of information, signals that are transported from one part of the organism to another.
Nervous regulation is mediated by a system of glial cells mutually interconnected through hollow and very long projections, ll addresses itself to a special receptor, it is very rapid but it cannot embrace all cells of the organism. The molecular basis of this type of regulation are changes in ion concentrations inside and outside the nerve cells which initiate and propagate the transmission of nerve impulses. The impulse is transmitted to another cell at the end plate through molecular mediators.
The molecular basis of hormonal regulation are hormones which can reach all cells of the organism and affect their function but only some cells (those of the target tissues) are receptive to the hormonal stimulus specifically. To increase the efficiency of regulation, hormones are often transported from the cell of origin to the target tissue in association with a specific protein. Such regulation is slower than the nervous one but it may affect any cell in the organism provided it has the proper receptor. It is assumed that the basic process of hormonal regulation is the binding of the hormone to a surface receptor protein or to a component of the cytoplasm.
The central nervous system is superior to the other parts of nervous communications as well as to hormonal regulation because it can store information transmitted by the signals into a memory, into specific structures of glial cells, and to use this information whenever necessary64.
64
Мельникова В.А., Барановская М.Е., Халикова Д.Г. Microbiology and
Biotechnology. Указ. соч.
136
Text 9. Essential Fatty Acids
Polyunsaturated fatty acids with 20 carbon atoms exhibit unique physiological activities in the human body, for example lowering of cholesterol and triacylglycerols in plasma, prevention of atherosclerosis and other cardiovascular diseases and reduction of collagen-induced thrombocyte aggregation. Moreover, these fatty acids are of great value in the nutrition of edible marine animals reared in man-culture, and as precursors of eicosanoid hormones. Potential sources of such fatty acids include fungi, mainly lower Phyco-mycetes, microalgae, viz. dinoflagellates, diatoms and unicellular red algae, marine macroalgae, particularly Phaeophyta and Rhodophyta, and mosses. The biomass may be enriched with Cao-polyunsaturated fatty acids by chilling, nitrogen starvation, controlled illumination and incubation with lipophilic compounds.
Polyunsaturated fatty acids, especially those with 20 carbon atoms, are currently receiving attention in view of their physiological, industrial and pharmaceutical value. So far, these fatty acids are obtained from animals, e.g. fish oil, which makes their large-scale preparation rather uneconomical. Within the past decade much work has been done on polyunsaturated fatty acids in a variety of microorganisms and lower plants. The major objectives of the present article are to review these studies and discuss the biotechnological potential for providing an economical source of these valuable compounds.
The designation "essential" is related to mammals and, more precisely, to man. The mammalian route of fatty acid biosynthesis is more limited than that of plants and microorganisms. This is true as far as polymerization and desaturation reactions are concerned. Thus, it is known that condensation of C2-units in mammals occurs only up to the C18-stage. Furthermore, double bonds can be subsequently introduced at only four positions, ∆4, ∆5, ∆6 and ∆9. Mammals lack the ability to introduce any double bonds at carbon atoms between C-9 and the terminal methyl group. This implies that such living systems cannot synthesize linoleic (18:2 ∆9, ∆12 or ω6; ω designates counting from the methyl group) and linolenic (18:3 ∆9, ∆12, ∆15 or ω3) acids. These two fatty acids are however, needed by mammals, and must be supplied in their diet, hence the term "essential"65.
65
Мельникова В.А., Барановская М.Е., Халикова Д.Г. Microbiology and
Biotechnology. Указ. соч.
137
Part 7. ПРАКТИКУМ ПИСЬМЕННОГО ПЕРЕВОДА
История биотехнологии
Впервые термин «биотехнология» применил венгерский
инженер Карл Эреки в 1917 году.
Случаи использования в промышленном производстве микроорганизмов или их ферментов, обеспечивающих технологический процесс, известны издревле, однако систематизированные научные исследования позволили существенно расширить арсенал методов и средств биотехнологии.
Так, в 1814 году петербургский академик К. С. Кирхгоф (биография) открыл явление биологического катализа и пытался биокаталитическим путём получить сахар из доступного отечественного сырья (до середины XIX века сахар получали только из сахарного тростника). В 1891 году в США японский биохимик Дз. Такамине получил первый патент на использование ферментных препаратов в промышленных целях: учёный предложил применить диастазу для осахаривания растительных отходов.
В начале XX века активно развивалась бродильная и микробиологическая промышленность. В эти же годы были предприняты первые попытки наладить производство антибиотиков, пищевых концентратов, полученных из дрожжей, осуществить контроль ферментации продуктов растительного и животного происхождения.
Первый антибиотик — пенициллин — удалось выделить и очистить до приемлемого уровня в 1940 году, что поставило новые задачи: поиск и налаживание промышленного производства лекарственных веществ, продуцируемых микроорганизмами, работа над удешевлением и повышением уровня биобезопасности новых лекарственных препаратов66.
66
http://www.biofit.ru/biotehnologii/Page-11.html
138
Биотехнология
Термин «биотехнология» был введен в 1917 г. венгерским инженером Карлом Эреки и характеризовал все виды работ, при которых из сырьевых материалов с помощью живых организмов производятся те или иные продукты. По определению академика А.А. Баева (1984), биотехнология – это использование живых организмов и их систем в промышленных целях. Поэтому несмотря на то, что большие материальные затраты и длительное время уходит на фундаментальные исследования, основной целью биотехнологии является получение коммерческого продукта, рентабельного производства и, следовательно, того, что необходимо людям в большей или меньшей степени.
Биотехнология формировалась как междисциплинарная наука и является на сегодняшний день самостоятельной, интенсивно развивающейся отраслью. Ее биологическая составляющая относится к сфере промышленной микробиологии и биохимии, а молекулярная – к областям молекулярной биологии, молекулярной генетики и энзимологии нуклеиновых кислот. Благодаря этому сочетанию сталовозможным более детальное изучение внутриклеточных процессовклетки, систем наследования и экспрессии генов. Усовершенствование методов клеточной и молекулярной биотехнологии позволило управлять наследственностью и жизнедеятельностью животных, растений и микроорганизмов, создавать организмы с новыми полезными для человека свойствами, ранее не наблюдавшимися в природе.
На сегодняшний день выделяют три основных направления биотехнологии: промышленная биотехнология (промышленная микробиология), культура растительных и животных клеток и тканей и генная инженерия.
Отдельные биотехнологические процессы, используемые в различных сферах практической деятельности человека, известны с древних времен. К ним относятся хлебопечение, виноделие, приготовление кисломолочных продуктов и т. д. В большинстве этих процессов используются микроорганизмы. Быстрый рост и огромное генетическое разнообразие микроорганизмов позволяют за короткий промежуток времени осуществить синтез больших количеств требуемого продукта в строго контролируемых условиях67.
67
http://www.biosoil.ru/files/00006056.pdf
139
Достижения биотехнологии
С помощью методов генной инженерии (перенос чужеродных генов, придающих новые полезные свойства организму хозяина) удалось видоизменить структуру и содержание современной промышленной микробиологии. Во-первых, существенно повысилась продуктивность промышленных микроорганизмов – продуцентов классических продуктов путем введения дополнительных генов, увеличения их количества или активности. Во-вторых, вводя в микробную клетку новые гены, удалось изменить питательные потребности микроорганизма. При стимулировании микроорганизмов к синтезированию несвойственных им веществ увеличили разнообразие биотехнологической продукции – некоторые белки человека, клонированные в микробной клетке, интерфероны, интерлейкины а также инсулин находят в настоящее время терапевтическое применение. Аналогичными методами стало возможным преобразование клеток бактерий, дрожжей и млекопитающих в «фабрики» для масштабного производства антибиотиков, белков, жиров, аминокислот, а также для получения безопасных и дешевых вакцин.
Уже 2002 г. в мире получено разрешение на применение более 30 лекарственных препаратов, созданных методами генной инженерии. В стадии клинического изучения находится более 100 биопрепаратов, еще более 500 – на стадии разработки, причем большинство из них предназначены для лечения болезней, которые до настоящего времени считались неизлечимыми.
По подсчетам специалистов, ежегодный объем мирового фармацевтического рынка составляет около 402 млрд долларов (2000 г.) и постоянно растет. Большая часть коммерческих разработок в области молекулярной биотехнологии приходится на США (French Biotechnology Industry Association, 2002). Единственным конкурентом США в этой области сегодня можно считать Китай. Это связано с тем, что правительство Китая объявило биотехнологию «стратеги- ческой индустрией» и национальным приоритетом. Интенсивное развитие биотехнологических компаний в Китае сохраняется и к настоящему моменту (SciDev.Net, 20 декабря 2004 г.)68.
68
http://www.biosoil.ru/files/00006056.pdf
140